Home
Browse
Search
Statistics
About
Usage
PMID: 11443282
Hammerle MM, Aleksandrov AA, Chang XB, Riordan JR
A novel CFTR disease-associated mutation causes addition of an extra N-linked oligosaccharide.
Glycoconj J. 2000 Nov;17(11):807-13.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
3
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:3:19
status:
NEW
view ABCC7 p.Thr908Asn details
This substitution (
T908N
) creates a consensus sequence (N X S=T) for addition of an N-linked oligosaccharide chain near the C-terminal end of EL4.
Login to comment
5
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:5:13
status:
NEW
view ABCC7 p.Thr908Asn details
However, the
T908N
site is used, even though it is within four residues of the predicted membrane interface and the oligosaccharide chain added binds calnexin, a resident chaperone of the ER membrane.
Login to comment
13
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:13:156
status:
NEW
view ABCC7 p.Thr908Asn details
However, while analyzing the functional impact of missense mutations in the putative extracytoplasmic loops (ELs) of the protein [7], we realized that one (
T908N
) created a consensus sequence (N X S=T) for N-glycosylation.
Login to comment
20
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:20:28
status:
NEW
view ABCC7 p.Thr908Asn details
BHK cells stably expressing
T908N
-CFTR were similarly established.
Login to comment
23
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:23:72
status:
NEW
view ABCC7 p.Thr908Asn details
ABCC7 p.Asn900Asp
X
ABCC7 p.Asn900Asp 11443282:23:65
status:
NEW
view ABCC7 p.Asn900Asp details
ABCC7 p.Thr910Asn
X
ABCC7 p.Thr910Asn 11443282:23:81
status:
NEW
view ABCC7 p.Thr910Asn details
Tel.: 480-301-6206; Fax: 480-301-7017; E-mail: riordan@mayo.edu
N900D
,
T908N
or
T910N
to produce a CFTR with different numbers or no consensus site for glycosylation on extracytoplasmic loop 4.
Login to comment
46
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:46:96
status:
NEW
view ABCC7 p.Thr908Asn details
Single channel records Microsomal vesicles were isolated from BHK cells expressing wildtype and
T908N
CFTR and phosphorylated with protein kinase A [17].
Login to comment
52
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:52:37
status:
NEW
view ABCC7 p.Thr908Asn details
Reconstruction and expression of the
T908N
variant in BHK cells resulted in the synthesis of a protein which ran with reduced mobility in SDS-PAGE (Figure 1B) consistent with the possibility that this additional N-glycosylation site had been used.
Login to comment
54
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:54:77
status:
NEW
view ABCC7 p.Thr908Asn details
The sialidase treatment increased the mobility of both the wild-type and the
T908N
variant substantially, indicating that the oligosaccharide chains are highly sialylated.
Login to comment
55
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:55:120
status:
NEW
view ABCC7 p.Thr908Asn details
After N-glycosidase F treatment the mobility is increased further and the deglycosylated form of both the wild-type and
T908N
migrate to the same position.
Login to comment
57
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:57:49
status:
NEW
view ABCC7 p.Thr908Asn details
The difference in mobility between wild-type and
T908N
was entirely eliminated after cells were grown in presence of the inhibitor.
Login to comment
60
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:60:51
status:
NEW
view ABCC7 p.Thr908Asn details
(A) Sketch of CFTR topology indicating position of
T908N
relative to the membrane and native glycosylation sites at N894 and N900.
Login to comment
61
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:61:42
status:
NEW
view ABCC7 p.Thr908Asn details
(B) Cells stably expressing wild type and
T908N
-CFTR were lysed in NP-40 lysis buffer (see Materials and methods).
Login to comment
65
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:65:31
status:
NEW
view ABCC7 p.Thr908Asn details
Cells expressing wild-type and
T908N
-CFTR were pulse labeled and chased as described in Methods. oligosaccharyl transferase and is an acceptor of an N-linked oligosaccharide chain.
Login to comment
69
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:69:118
status:
NEW
view ABCC7 p.Thr908Asn details
Conversion of precursor to product occurs with low efficiency ($ 30%) but this also is similar with wild-type and the
T908N
variant.
Login to comment
70
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:70:40
status:
NEW
view ABCC7 p.Thr908Asn details
Hence the additional oligosaccharide in
T908N
does not have a profound effect on the biosynthetic processing of CFTR.
Login to comment
89
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:89:33
status:
NEW
view ABCC7 p.Thr908Asn details
As already noted in Figure 1 the
T908N
variant in the wild-type background has substantially decreased mobility.
Login to comment
90
ABCC7 p.Thr910Asn
X
ABCC7 p.Thr910Asn 11443282:90:29
status:
NEW
view ABCC7 p.Thr910Asn details
However, the mobility of the
T910N
variant also is somewhat slower compared to wild-type suggesting that it also can serve as oligosaccharyl transferase acceptor.
Login to comment
98
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:98:0
status:
NEW
view ABCC7 p.Thr908Asn details
T908N
reduces the rate of 36 Cl7 efflux and alters both the single channel gating kinetics and conductance of CFTR.
Login to comment
108
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:108:123
status:
NEW
view ABCC7 p.Thr908Asn details
As shown in Figure 1B, removal of sialic acid from complex glycosylated CFTR results in a higher mobility of wild-type and
T908N
.
Login to comment
114
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:114:94
status:
NEW
view ABCC7 p.Thr908Asn details
Similar amounts of calnexin were detected in CFTR immunoprecipitates containing wild-type and
T908N
, and 894N and 900N alone whereas much less was detected when single oligosaccharide chains were present at 908N and especially at 910N (Figure 3).
Login to comment
116
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:116:138
status:
NEW
view ABCC7 p.Thr908Asn details
To assess how the presence of a third oligosaccharide chain influences CFTR function, the rate of 36 Cl7 efflux from cells expressing the
T908N
variant was compared with wild-type and was found to be reduced about 50% (Figure 4A).
Login to comment
119
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:119:26
status:
NEW
view ABCC7 p.Thr908Asn details
Thus both measures of the
T908N
CFTR chloride channel indicate that while still active, it is substantially altered from the wild-type.
Login to comment
120
ABCC7 p.Thr908Asn
X
ABCC7 p.Thr908Asn 11443282:120:113
status:
NEW
view ABCC7 p.Thr908Asn details
Discussion Although all types of mutations have been detected in the CFTR gene of patients with cystic fibrosis,
T908N
is the only example of a single residue substitution that introduces a consensus site for glycosylation.
Login to comment